Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez de Villavicencio-Díaz, Teresa, Ramos Gómez, Yassel, Oliva Argüelles, Brizaida, Fernández Masso, Julio R., Rodríguez-Ulloa, Arielis, Cruz García, Yiliam, Guirola-Cruz, Osmany, Perez-Riverol, Yasset, Javier González, Luis, Tiscornia, Inés, Victoria, Sabina, Bollati-Fogolín, Mariela, Besada Pérez, Vladimir, Guerra Vallespi, Maribel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Biochemistry, Genetics and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534583/
https://www.ncbi.nlm.nih.gov/pubmed/26306321
http://dx.doi.org/10.1016/j.dib.2015.06.024
Descripción
Sumario:CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above analysis.

Ejemplares similares